To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort.Ann Neurol. 1994; 35: 709-716
- Genetic and familial aspects of narcolepsy.Neurology. 1998; 50: S16-S22
- ICSD-2-International classification of sleep disorders. Diagnostic and coding manual. 2nd edition. American Academy of Sleep Medicine, Westchester (IL)2005
- Health-related quality of life effects of modafinil for treatment of narcolepsy.Sleep. 1999; 22: 757-765
- The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.Arch Neurol. 2002; 59: 1553-1562
- Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.Sleep Med Rev. 2005; 9: 269-310
- Pharmacological aspects of human and canine narcolepsy.Prog Neurobiol. 1997; 52: 27-78
- Clinical features of narcolepsy: Japanese experience.in: Honda Y. Juji T. HLA in narcolepsy. Springer-Verlag, New York1988: 24-57
- Stability of cataplexy over several months-information for the design of therapeutic trials.Sleep. 1994; 17: 265-273
- Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.J Clin Neurophysiol. 2001; 18: 78-105
- A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.Sleep. 2002; 25: 42-49
- Hypocretin (orexin) deficiency in human narcolepsy.Lancet. 2000; 355: 39-40
- CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies.Neurology. 2003; 61: 823-825
- Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.Neurology. 2004; 62: 138-140
- Life effects of narcolepsy: measures of negative impact, social support and psychological well-being.in: Goswanmi M. Pollak C.P. Cohen F.L. Loss, grief and care: psychosocial aspects of narcolepsy, vol. 5. Haworth Press, New York1992: 1-22
- Narcolepsy and syndromes of primary excessive daytime somnolence.Semin Neurol. 2004; 24: 271-282
- Kleine-Levin syndrome ethiopathogenesis and treatment.Acta Univ Carol Med Monogr. 1988; 128: 5-94
- Kleine Levin syndrome.in: Krieger M.H. Roth T. Dement W.C. Principles and practice of sleep medicine. WB Saunders, Philadelphia1989: 377-378
- The nature of the narcoleptic sleep attack.Neurology. 1966; 16: 18-33
- Excessive daytime sleepiness and pathophysiology of narcolepsy-cataplexy: a laboratory perspective.Sleep. 1986; 9: 205-215
- A study on cataplexy.Arch Neurol. 1974; 31: 255-261
- Is narcolepsy REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans.Neurosci Res. 2000; 38: 437-446
- The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness.Sleep. 1996; 19: 727-730
- Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.Sleep. 1997; 20: 620-629
- High prevalence of isolated sleep paralysis: Kanashibari phenomenon in Japan.Sleep. 1987; 10: 279-286
- Hypnagogic and hypnopompic hallucinations: pathological phenomena?.Br J Psychiatry. 1996; 169: 459-467
- HLA antigens in Japanese patients with narcolepsy: all the patients were DR2 positive.Tissue Antigens. 1984; 24: 316-319
- HLA class II studies in 509 narcoleptic patients.Sleep Res. 1997; 26: 433
- Is narcolepsy an autoimmune disease?.in: Smirne S. Francesci M. Ferini-Strambi L. Proceedings of the Third Milano International Symposium, September 18–19 Sleep, Hormones, and the Immune System. Masson, Milan1992: 29-38
- Elevated antibodies to streptococcal antigens in narcoleptic subjects.Sleep Res. 1989; 18: 201
- Streptococcal antibodies in narcolepsy and idiopathic hypersomnia.Sleep Res. 1989; 18: 271
- CSF immune variable in patients with narcolepsy.Acta Neurol Scand. 1990; 81: 253-254
- Immunological features of narcolepsy in Japan.in: Honda Y. Juji T. HLA in narcolepsy. Springer-Verlag, New York1988: 150-157
- Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.Sleep. 2002; 25: 719-723
- Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.Biol Psychiatry. 2005; 58: 504-509
- Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.Proc Natl Acad Sci U S A. 1991; 88: 3475-3478
- Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.Cell. 1999; 98: 437-451
- The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.Cell. 1999; 98: 365-376
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.Nat Med. 2000; 6: 991-997
- Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy.Ann Neurol. 2001; 50: 381-388
- Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.Sleep. 2002; 25: 733-736
- CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.J Sleep Res. 2002; 11: 91-93
- Reduced number of hypocretin neurons in human narcolepsy.Neuron. 2000; 27: 469-474
- Hypocretin levels in sporadic and familial cases of canine narcolepsy.Neurobiol Dis. 2001; 8: 525-534
- The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.Proc Natl Acad Sci U S A. 1998; 95: 322-327
- Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.Cell. 1998; 92: 573-585
- Neurons containing hypocretin (orexin) project to multiple neuronal systems.J Neurosci. 1998; 18: 9996-10015
- To eat or to sleep? Orexin in the regulation of feeding and wakefulness.Annu Rev Neurosci. 2001; 24: 429-458
- The role of hypocretins (orexins) in sleep regulation and narcolepsy.Annu Rev Neurosci. 2002; 25: 283-313
- Decreased brain histamine contents in hypocretin/orexin receptor-2 mutated narcoleptic dogs.Neurosci Lett. 2001; 313: 125-128
- Arousal effect of orexin A depends on activation of the histaminergic system.Proc Natl Acad Sci U S A. 2001; 98: 9965-9970
- Orexins activate histaminergic neurons via the orexin 2 receptor.Biochem Biophys Res Commun. 2002; 290: 1237-1245
- Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus.J Neurosci. 2001; 21: 9273-9279
- CSF histamine content is decreased in hypocretin-deficient human narcolepsy.Sleep. 2002; 25: A476
- Wake promoting effects of thioperamide, a histamine H3 antagonist in orexin/ataxin-3 narcoleptic mice.Sleep. 2004; 27: A241
- Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation.Neuroreport. 2001; 12: 993-997
- Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.Eur J Neurosci. 2001; 14: 1075-1081
- Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness.J Neurosci. 2003; 23: 3555-3560
- Behavioral correlates of activity in identified hypocretin/orexin neurons.Neuron. 2005; 46: 787-798
- Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle.J Neurosci. 2005; 25: 6716-6720
- A neural circuit for circadian regulation of arousal.Nat Neurosci. 2001; 4: 732-738
- Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement.Am J Physiol Regul Integr Comp Physiol. 2002; 283: R1079-R1086
- Alerting effects of naps in patients with narcolepsy.Sleep. 1986; 9: 194-199
- Treatment of narcolepsy.in: Thorpy M.J. Handbook of sleep disorders. Marcel Dekker, New York1990: 235-258
- Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy.Sleep. 1993; 16: 444-456
- Problems and coping strategies identified by narcoleptic patients.J Neurosurg Nurs. 1984; 16: 326-334
- Stimulant medication survey.The Eye Opener. 1992; : 1-3
- Narcolepsy and its treatment with stimulants.Sleep. 1994; 17: 352-371
- Gamma-hydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.Sleep. 1993; 16: 216-220
- Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.Biol Psychiatry. 1989; 26: 331-343
- Narcolepsy: genetic predisposition and neuropharmacological mechanisms.Sleep Med Rev. 2000; 4: 57-99
- Pathophysiology of narcolepsy.in: Kryger M.H. Roth T. Dement W.C. Principles and practice of sleep medicine. WB Saunders, Philadelphia2000: 663-675
- Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.Sleep Research Online. 1998; 1 (Available at:) (Accessed December 24, 2005): 49-61
- Dopaminergic role in stimulant-induced wakefulness.J Neurosci. 2001; 21: 1787-1794
- Effects of imipramine, chlorimipramine, and fluoxetine on cataplexy in dogs.Pharmacol Biochem Behav. 1976; 5: 599-602
- Monoaminergic mechanisms and experimental cataplexy.Ann Neurol. 1981; 10: 369-376
- Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area.J Neurophysiol. 2001; 85: 2008-2016
- Distribution of orexin neurons in the adult rat brain.Brain Res. 1999; 827: 243-260
- Orexin A activates locus coeruleus cell firing and increases arousal in the rat.Proc Natl Acad Sci U S A. 1999; 96: 10911-10916
- Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.J Comp Neurol. 1999; 415: 145-159
- Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin ligand deficient narcoleptic dog.Sleep. 2003; 6: 953-959
- Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.Sleep. 2002; 25: 337-339
- A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid.J Child Neurol. 2002; 17: 537-539
- Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.Neuron. 2001; 30: 345-354
- The hypocretin/orexin system in health and disease.Biol Psychiatry. 2003; 54: 87-95
Article info
Identification
Copyright
© 2006 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
